Swetha RaniKanduri United StatesOchsner Health, New Orleans, LA

Swetha RaniKanduri
I am Swetha Kanduri, completed medical school from Osmania medical college in India, residency from University of Alabama and Fellowship from University of Mississippi Medical Center. Currently working as Assistant Professor at Ochsner Health and serves as Associate Fellowship Program Director for the Nephrology Fellowship Program. Research Interest in Hepatorenal syndrome and Onco-Nephrology with particular focus on electrolyte abnormalities in cancer patients, GLP-1RA in cancer patients ________________________________________
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/d195a7b7d7c5a9ccca222bf401e21952.jpeg
First Name
Swetha Rani
Last Name
Kanduri
Institution
Country.
United States

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
Looking into the Crystal Ball – Where Will We Be 5 Years from Now?
SK2002
RajkumarSharma Chair IndiaDirector and Head of Department of Nephrology, Medanta Hospital, Lucknow
Swetha RaniKanduri Chair United StatesOchsner Health, New Orleans, LA
  • Evaluating Kidney Allograft Dysfunction
    SK2002-001
    SumitMohan Speaker United StatesColumbia University
  • Advances in Glomerular Disease Treatment
    SK2002-02
    JonathanBarratt Speaker United KingdomUniversity of Leicester, Leicester, UK
  • Risk Prediction in AKI and CKD
    SK2002-03
    NavdeepTangri Speaker CanadaUniversity of Manitoba, SOGH Chronic Disease Innovation Centre
  • Prioritizing Patient-friendly Dialysis
    SK2002-04
    EdwinaBrown Speaker United KingdomImperial College Healthcare NHS Trust
  • Glomerular Disease Diagnostics
    SK2002-01
    SanjeevSethi Speaker United StatesMayo Clinic
  • Q&A
    SK2002-06
Brahmkamal Hall - Plenary Hall

Sunday, February 9, 2025

Time Session
9 a.m.
10:30 a.m.
Metabolic Crossroads: Kidneys, Liver Disease, and the Gut
IK06
GloriaAshuntantang Chair CameroonUniversity of Bamenda, Cameroon
Narayan Prasad Chair IndiaSanjay gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Dr Sree BhushanRaju Chair India
  • Hepatorenal Syndrome and New Treatments for AKI in Cirrhosis
    IK06-01
    Swetha RaniKanduri Speaker United StatesOchsner Health, New Orleans, LA
  • Do Gut Microbiota Contribute to Kidney Disease? If so, What Can We Do About it?
    IK06-02
    GrietGlorieux Speaker BelgiumUGent
  • What Should Nephrologists Know About Metabolic Dysfunction-associated Fatty Liver Disease
    IK06-03
    Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore
  • Measuring Kidney Function in Liver Disease - Pitfalls and Solutions
    IK06-04
    SmitaDivyaveer Speaker IndiaPOST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA
  • Q&A
    IK06-05
Amaltas Hall B101-A